The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Sintilimab plus gemcitabine and cisplatin as a first-line treatment for patients with advanced biliary tract cancer: A biomolecular exploratory, phase II clinical trial.
 
Zhen-gang Yuan
No Relationships to Disclose
 
Tian-mei Zeng
No Relationships to Disclose
 
Guang Yang
No Relationships to Disclose
 
Cheng Lou
No Relationships to Disclose
 
Wei Wei
No Relationships to Disclose
 
Chen-jie Tao
No Relationships to Disclose
 
Xi-yun Chen
No Relationships to Disclose
 
Qin Han
No Relationships to Disclose
 
Zhuo Cheng
No Relationships to Disclose
 
Pei-pei Shang
No Relationships to Disclose
 
Yu-long Dong
No Relationships to Disclose
 
He-ming Xu
No Relationships to Disclose
 
Lie-ping Guo
No Relationships to Disclose
 
Dong-sheng Chen
No Relationships to Disclose
 
Yunjie Song
No Relationships to Disclose
 
Chuang Qi
No Relationships to Disclose
 
Wanglong Deng
No Relationships to Disclose